Efficacy of Intraperitoneal Versus Intravenous Lidocaine for Postcesarean Pain Relief
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
Objective: To evaluate intraperitoneal (IP) lidocaine administration and intravenous (IV)
lidocaine infusion for postoperative pain control after cesarean section.
Study design: prospective randomized, double-blind, placebo-controlled study. Patients and
methods: Initially, 165 pregnant full-term females, indicated to be underwent elective
cesarean delivery for various indications were randomized equally to either group C (control,
IP and IV saline), group IP (intraperitoneal lidocaine administration), or group IV
(intravenous lidocaine infusion).Five patients were excluded from each group for various
reasons. The outcome measures were postoperative pain scoring, total pethidine consumption
and the need for postoperative analgesia.